Morgan Stanley lowered the firm’s price target on Edgewell Personal Care (EPC) to $32 from $35 and keeps an Underweight rating on the shares after a fiscal Q1 EPS miss. “More significantly,” Edgewell lowered FY EPS guidance to the low-end of the prior range and gave weak fiscal Q2 organic sales growth guidance, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EPC:
- Edgewell Personal Care price target lowered to $35 from $37 at Wells Fargo
- Edgewell Personal Care: Attractive Buy Rating Amidst Low Valuation and Future Growth Prospects
- Edgewell Personal Care price target lowered to $30 from $33 at Barclays
- Edgewell Personal Care Co. Reports Q1 Fiscal 2025 Results
- Edgewell Personal Care Co’s Mixed Earnings Call Insights